Author

DM Somford

Urologist, Canisius Wilhelmina Hospital, Nijmegen (NL) - Cited by 4,253 - Prostate Cancer - Bladder Cancer - Imaging - Robotic Surgery

Biography

Dr.DM Somford  is currently working in Department of Urology, Canisius Wilhelmina Hospital, Weg door Jonkerbos 100, 6532 SZ, Nijmegen, The Netherlands. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work.
Title
Cited by
Year
Lutetium-177-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer: a prospective pilot study
BM Privé, SMB Peters, CHJ Muselaers, IM van Oort, MJR Janssen, ...Clinical Cancer Research 27 (13), 3595-3601, 2021202
48
2021
Niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer
KN Chi, D Rathkopf, MR Smith, E Efstathiou, G Attard, D Olmos, JY Lee, ...Journal of Clinical Oncology 41 (18), 3339-3351, 2023202
14
2023
Preoperative PSMA-PET/CT as a predictor of biochemical persistence and early recurrence following radical prostatectomy with lymph node dissection
DJH Baas, M Schilham, R Hermsen, JMS de Baaij, H Vrijhof, RJ Hoekstra, ...Prostate Cancer and Prostatic Diseases 25 (1), 65-70, 2022202
11
2022
Real-world outcomes of sequential androgen-receptor targeting therapies with or without interposed life-prolonging drugs in metastatic castration-resistant prostate cancer …
MCP Kuppen, HM Westgeest, AJM van den Eertwegh, ...European urology oncology 4 (4), 618-627, 2021202
9
2021
The effect of different types of prostate biopsy techniques on post-biopsy infectious complications
SCM Tops, JGA Grootenhuis, AM Derksen, F Giardina, E Kolwijck, ...The Journal of Urology 208 (1), 10-118, 2022202
9
2022
What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study
HB Luiting, S Remmers, R Valdagni, ER Boevé, F Staerman, J Rueb, ...Prostate Cancer and Prostatic Diseases 24 (4), 1048-1054, 2021202
9
2021
A prospective multicenter comparison study of risk-adapted ultrasound-directed and magnetic resonance imaging–directed diagnostic pathways for suspected prostate cancer in …
IM Wagensveld, DF Osses, PM Groenendijk, FM Zijta, MB Busstra, ...European Urology 82 (3), 318-326, 2022202
9
2022
Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line …
E Boerrigter, GE Benoist, IM van Oort, GW Verhaegh, O van Hooij, ...Molecular Oncology 15 (9), 2453-2465, 2021202
7
2021
The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population
HM Westgeest, MCP Kuppen, AJM van den Eertwegh, R de Wit, ...Prostate Cancer and Prostatic Diseases 24 (3), 81-89, 2021202
7
2021
Rectal Culture-Based Versus Empirical Antibiotic Prophylaxis to Prevent Infectious Complications in Men Undergoing Transrectal Prostate Biopsy: A Randomized, Nonblinded …
SCM Tops, E Kolwijck, EL Koldewijn, DM Somford, FJM Delaere, ...Clinical Infectious Diseases 76 (7), 1188-1196, 2023202
5
2023
Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
N Beije, IE de Kruijff, JJ de Jong, SO Klaver, P de Vries, RAL Jacobs, ...ESMO Open 7 (2), 100416, 2022202
5
2022
Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial
SK Pal, DM Somford, P Grivas, SS Sridhar, S Gupta, J Bellmunt, ...Future Oncology 18 (21), 299-2614, 2022202
5
2022
Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands
FJ Hinsenveld, JL Boormans, HG van der Poel, DKE van der Schoot, ...Urologic Oncology: Seminars and Original Investigations 0 (2), 60. e1-60. e9, 2022202
4
2022
Functional and oncological outcomes of salvage cryosurgery for radiorecurrent prostate cancer
L Exterkate, M Peters, DM Somford, H VergunstBJU international 128 (1), 6-56, 2021202
4
2021
Lymph node staging with fluorine-18 prostate specific membrane antigen 1007-positron emission tomography/computed tomography in newly diagnosed intermediate-to high-risk …
R Hermsen, EBC Wedick, MJM Vinken, LWM van Kalmthout, ...European Journal of Nuclear Medicine and Molecular Imaging 49 (11), 929-97, 2022202
3
2022
High-Intensity Care in the End-of-Life Phase of Castration-Resistant Prostate Cancer Patients: Results from the Dutch CAPRI-Registry
HM Westgeest, MCP Kuppen, FAJM van den Eertwegh, IM van Oort, ...Journal of palliative medicine 24 (12), 1789-1797, 2021202
3
2021
How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come.
MGM Schilham, M Rijpkema, T Scheenen, R Hermsen, JO Barentsz, ...European Urology, S030-838 () 0634, 0
2
2022
Confocal laser microscopy for assessment of surgical margins during radical prostatectomy
DJH Baas, W Vreuls, JPM Sedelaar, H Vrijhof, RJ Hoekstra, SF Zomer, ...BJU International, 0
2
2022
Optimization of Preoperative Lymph Node Staging in Patients with Muscle-Invasive Bladder Cancer Using Radiomics on Computed Tomography
MPA Starmans, LS Ho, F Smits, N Beije, I de Kruijff, JJ de Jong, ...Journal of Personalized Medicine 1 (5), 76, 0
2
2022
Incidence and survival of castration-resistant prostate cancer patients with visceral metastases: results from the Dutch CAPRI-registry
GPA van den Bergh, MCP Kuppen, HM Westgeest, N Mehra, ...Prostate Cancer and Prostatic Diseases 6 (1), 16-169, 030
2
2023

Referred From: https://scholar.google.com/citations?hl=en&user=a8cZ4AYAAAAJ

Cited by
Citations 4253
h-index 24
i10-index 34
Recommended Journals
Open Access Journals